Teva fined €462.6M over Copaxone patent and competition allegations

Generics giant Teva Pharmaceuticals has been hit with another fine related to its blockbuster multiple sclerosis drug Copaxone, this time by the European Commission. Teva will have to pay €462.6 million ...